Skin consultation

The skin consultation covers the standard MD-Dermatology scope across acne and acne-scarring, pigmentation patterns including melasma and post-inflammatory hyperpigmentation, anti-ageing trajectory concerns, skin-tightening and laxity, skin-texture and pore concerns, sensitive-skin and barrier-stress patterns, mole and lesion review, and selected medical-dermatology presentations. Recommendation calibration is case-driven; the framework explicitly avoids channelling every patient toward a single in-house signature pathway.

Pathway selection follows the suitability framework documented on the treatment suitability philosophy page. The dermatologist establishes what the patient is asking the pathway to do, the realistic options across the evidence base, the expected outcome range for the patient's skin and life-context, the residual-risk profile of each option, and the alternatives that the framework considered. The recommendation arrives at the consultation through that conversation rather than as a pre-decided pathway.

Yes. Multi-concern visits are common — for example acne plus pigmentation plus selected scarring, or anti-ageing trajectory plus melasma plus barrier-stress. The visit-length is calibrated for multi-concern complexity at the booking conversation. The framework prioritises the most pressing concern first and routes secondary concerns through the same written plan structure.

Yes — single-concern visits are equally valid. A patient who comes in for a specific acne-scar question, a specific pigmentation patch, or a specific mole assessment receives the same calibrated framework focused on that concern. The consultation does not push secondary cross-sells when the patient's presenting question is single-concern.

Sensitive presentations — selected pigmentation patterns, intimate-area dermatology, body-image-linked concerns, hormonal-axis-related skin presentations — are handled with appropriate clinical sensitivity. The consultation is conducted in private and the patient's comfort and dignity are prioritised. Patients can flag specific sensitivity preferences at the booking conversation.

Skin examination is calibrated to the presenting concern under appropriate clinical lighting. Selected cases include the use of magnification, dermoscopy for lesion or pigmentation review, Wood's lamp where pigment differentiation matters, or other appropriate tools. The framework treats the examination as a calibrated clinical step rather than as a scripted display. Areas not relevant to the presenting concern are not examined unless their relevance becomes apparent during the conversation.

Selected cases warrant dermoscopy — pigmented lesion review, selected pigmentation differential, scalp dermoscopy for hair-fall pathway differentiation, and selected inflammatory pattern review. The framework uses dermoscopy where it changes the assessment rather than as a routine scripted step. The dermoscopy page covers the technology layer.

The consultation includes review of the patient's current and prior skincare regime where relevant — actives in current use, frequency, prior triggers, prior reactions, and the trajectory of skin response. The framework treats the regime as a substantive part of the assessment rather than as background; many skin presentations are calibrated by the cumulative effect of the regime.

Skin-condition history covers prior dermatology consultations, prior pathway responses, family-history patterns where they help, hormonal-axis context for selected presentations, and selected systemic-disease overlays. The framework treats history as informing the recommendation as much as the examination does. Patients with prior reports are encouraged to bring them; the consultation can begin without them too.

For pathways where progress tracking matters — acne and scar pathways, pigmentation trajectories, anti-ageing pathways with structured monitoring — a photographic baseline is established. Capture happens only after the patient is informed and gives consent at that moment. Default use is clinical-record-only. Operational detail on photographic tracking sits at the medical photography page.

Indian skin contexts shape recommendations across pathway groups. Pigmentation interaction with thermal, chemical, and laser pathways differs in Fitzpatrick III–VI skin compared with Fitzpatrick I–II skin, and parameter selection accounts for that. Hyperpigmentation risk after inflammatory triggers is higher in pigmented skin, and the framework calibrates accordingly. The laser safety on Indian skin page covers the technical framework.

Yes. For many skin presentations, topical pharmacology is the foundation pathway with procedural adjuncts where appropriate. Acne management is structured topically-and-orally with procedural support for selected sub-types. Pigmentation pathways are typically topical-and-photoprotection foundations with calibrated procedural adjuncts. Anti-ageing trajectory typically integrates topical actives with selected procedural touch-points.

Selected presentations warrant oral pharmacology — moderate-to-severe acne, selected hormonal-axis presentations, selected immune-mediated dermatology, and selected systemic-context overlays. The framework treats oral pathways as part of the standard MD-Dermatology toolkit and calibrates them appropriately, with relevant blood-work review and informed-consent conversation around expected experience and residual risk.

Procedural pathway selection follows the suitability framework. Common procedural categories include calibrated chemical peel pathways, laser-based pigmentation and resurfacing pathways, microneedling-RF pathways, energy-based skin-tightening pathways, and selected injectable pathways within the dermatology scope. Specific protocol parameters are calibrated to the case rather than promised in advance.

The framework respects patient autonomy without abandoning clinical responsibility. Where the requested procedure is appropriate the framework proceeds with calibrated parameters. Where it is not — because of skin context, prior pattern, residual-risk profile, or because foundations need to be established first — the conversation surfaces what is appropriate and why. Selected requests cannot be honoured because they fall outside what is clinically defensible for the case.

Skin-pathway written plans cover the calibrated recommendation, the rationale, the realistic outcome range over an evidence-based timeline, the maintenance pattern (where one applies), the residual-risk profile, the per-component pricing for the case, the follow-up cadence, and any blood-work or referral routing. The patient takes the plan away from the visit and chooses if and when to act on it.

Outcomes are framed as a realistic range rather than as an absolute single figure. For acne-scar pathways the realistic range covers a calibrated improvement on the treated area against the baseline rather than a complete reset to scar-free skin; for melasma the realistic range covers a graded clearance with maintenance dependency rather than a fixed-final endpoint; for anti-ageing pathways the realistic range covers calibrated improvement against the trajectory rather than reversal of biological age. The framework states this honestly rather than over-claiming.

Every procedural pathway has a residual-risk profile that is discussed at the consent stage and surfaced in the written plan rather than hidden as a footnote. For laser-and-energy-based pathways residual-risk items include selected pigmentation responses, transient barrier disruption, and selected unusual response patterns. Residual-risk discussion in the framework is substantive content rather than legal-defensive language.

Multi-session pathway pricing is structured per-session with the bundle-level structure, where applicable, surfaced clearly so the patient understands what is being paid for what. Pre-bundled "package" deals are not the framework default; the consultation arrives at the recommended session count for the case rather than at a pre-bundled package that may exceed or fall short of the actual need.

Yes. Calibration changes — early-response review suggesting a different approach, the patient's context changing, an unexpected response pattern — are surfaced and a revised plan is produced rather than the original plan being held to as a sunk-cost commitment. The follow-up review cadence is the natural touch-point for revision.

Follow-up cadence is calibrated to the pathway. Active procedural pathways are typically reviewed at the relevant response window — weeks for selected medical-dermatology pathways, months for procedural-resurfacing pathways. Maintenance pathways for melasma, ageing trajectory, and selected acne-prone-skin patterns are reviewed six-monthly to annually. The cadence is included in the written plan from the start.

Yes, in selected contexts — follow-up reviews where in-person examination is not necessary, prescription continuity review where the regulatory framework supports it, and selected coordination touch-points. The Teleconsultation Policy in the policies section is the formal source.

The framework supports return visits for new concerns. A patient who came in originally for acne and later wants to address pigmentation or anti-ageing is welcome to return with a fresh consultation focused on the new concern. The continuity-of-care framework keeps the prior records accessible to the dermatologist for the new visit.

Per the Patient Privacy and Records Policy, skin-pathway records are governed as confidential, access-controlled health information. The dermatologist and the trained clinical-team members involved in the skin pathway are the only ones with appropriate access. Patient information is not transferred to external marketing parties through the framework absent specific consent. The privacy policy document carries the binding mechanics for skin-pathway records.